The importance of patient perception in the clinical assessment of benign prostatic hyperplasia and its management

BJU International

Volumn 95, Issue 1, 2005, Pages 15-19

  Hong, Sung Joon ^a   Rayford, Walter ^b   Valiquette, Luc ^c   Emberton, Mark ^d  

^a Yonsei University College of Medicine   (South Korea)

^b LOUISIANA STATE UNIV HLTH SCI C   (United States)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Benign prostatic hyperplasia; Bother; Impact; Quality of life; Symptoms

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; FINASTERIDE;

CHRONIC DISEASE; CLINICAL FEATURE; COMORBIDITY; DISEASE SEVERITY; DYSURIA; FLUID INTAKE; HUMAN; MALE; NOCTURIA; PERCEPTION; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATECTOMY; QUALITY OF LIFE; QUESTIONNAIRE; SEXUAL BEHAVIOR; SEXUAL FUNCTION; SHORT SURVEY; TREATMENT INDICATION; CLINICAL ASSESSMENT; HOSPITAL; MORTALITY; PATIENT SATISFACTION; PHYSICIAN; SEXUAL DYSFUNCTION; SHORT FORM 36; SYMPTOM; URINE FLOW RATE;

ATTITUDE TO HEALTH; FEAR; HUMANS; MALE; PERCEPTION; PROSTATIC HYPERPLASIA; QUALITY OF LIFE; QUESTIONNAIRES; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; URINARY RETENTION;

EID: 12544252439     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2005.05240.x     Document Type: Short Survey

References (37)

1. Bosch JL, Hop WC, Kirkels WJ, Schroder FH. Natural history of benign prostatic hyperplasia: appropriate case definition and estimation of its prevalence in the community. Urology 1995; 46 (Suppl. 3A): 34-40
2. Boyle P, Robertson C, Mazzetta C et al. The prevalence of lower urinary tract symptoms in men and women in four centres. The UrEpik study. BJU Int 2003; 92: 409-14
3. Jacobsen SJ, Guess HA, Panser L et al. A population-based study of health care-seeking behavior for treatment of urinary symptoms. The Olmsted County Study of Urinary Symptoms and Health Status Among Men. Arch Fam Med 1993; 2: 729-35
4. Roberts RO, Rhodes T, Panser LA et al. Natural history of prostatism: worry and embarrassment from urinary symptoms and health care-seeking behavior. Urology 1994; 43: 621-8
5. Sagnier PP, MacFarlane G, Teillac P, Botto H, Richard F, Boyle P. Impact of symptoms of prostatism on level of bother and quality of life of men in the French community. J Urol 1995; 153: 669-73
6. Girman CJ, Epstein RS, Jacobsen SJ et al. Natural history of prostatism: impact of urinary symptoms on quality of life in 2115 randomly selected community men. Urology 1994; 44: 825-31
7. Anonymous. A comparison of quality of life with patient reported symptoms and objective findings in men with benign prostatic hyperplasia. The Department of Veteran Affairs Cooperative Study of transurethral resection for benign prostatic hyperplasia. J Urol 1993; 150: 1696-700
8. DuBeau CE, Yalla SV, Resnick NM. Implications of the most bothersome prostatism symptom for clinical care and outcomes research. J Am Geriatr Soc 1995; 43: 985-92
9. Garraway WM, Russell EB, Lee RJ et al. Impact of previously unrecognized benign prostatic hyperplasia on the daily activities of middle-aged and elderly men. Br J Gen Pract 1993; 43: 318-21
10. Garraway WM, Kirby RS. Benign prostatic hyperplasia: effects on quality of life and impact on treatment decisions. Urology 1994; 44: 629-36
11. Calais Da Silva F, Marquis P, Deschaseaux P, Gineste JL, Cauquil J, Patrick DL. Relative importance of sexuality and quality of life in patients with prostatic symptoms. Eur Urol 1997; 31: 272-80
12. Hunter DJ, McKee M, Black NA, Sanderson CFB. Health status and quality of life of British men with lower urinary tract symptoms: results from the SF-36. Urology 1995; 45: 962-71
13. Mozes B, Maor Y, Shmueli A. The competing effects of disease states on quality of life of the elderly: the case of urinary symptoms in men. Qual Life Res 1999; 8: 93-9
14. Derrett S, Paul C, Morris JM. Waiting for elective surgery, effects on health-related quality of life. Int J Qual Health Care 1999; 11: 47-57
15. MacDonagh RP, Cliff AM, Speakman MJ, O'Boyle PJ, Ewings P, Gudex C. The use of generic measures of health-related quality of life in the assessment of outcome from transurethral resection of the prostate. Br J Urol 1997; 79: 401-8
16. Trueman P, Hood SC, Nayak U, Mrazek M. Prevalence of lower urinary tract symptoms and self-reported diagnosed 'benign prostatic hyperplasia' and their effect on quality of life in a community-based survey in men in the UK. BJU Int 1999; 83: 410-5
17. Selai CE, Elstner K, Trimble MR. Quality of life pre and post epilepsy surgery. Epilepsy Res 2000; 38: 67-74
18. Garratt AM, Hutchinson A, Russell I. Patient-assessed measures of health outcome in asthma: a comparison of four approaches. Respir Med 2000; 94: 597-606
19. Spencer S, Calverley PMA, Burge PS, Jones PW. Health status deterioration in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 122-8
20. Arocho R, McMillan CA, Sutton-Wallace P. Construct validation of the USA-Spanish version of the SF-36 health survey in a Cuban-American population with benign prostatic hyperplasia. Qual Life Res 1998; 7: 121-6
21. Frankel SJ, Donovan JL, Peters TI et al. Sexual dysfunction in men with lower urinary tract symptoms. J Clin Epidemiol 1998; 51: 677-85
22. Peters TJ. The relationship between LUTS and sexual function. Prostate Cancer Prostatic Dis 2001; 4: S2-S6
23. Boyle P, Robertson C, Mazzetta C et al. The association between lower urinary tract symptoms and erectile dysfunction in four centres: the UrEpik study. BJU Int 2003; 92: 719-25
24. Leliefeld HH, Stoevelaar HJ, McDonnell J. Sexual function before and after various treatments for symptomatic benign prostatic hyperplasia. BJU Int 2002; 89: 208-13
25. Jacobsen SJ, Jacobson DJ, Girman CJ et al. Natural history of prostatism: risk factors for acute urinary retention. J Urol 1997; 158: 481-7
26. Choong S, Emberton M. Acute urinary retention. BJU Int 2000; 85: 186-201
27. Pickard R, Emberton M, Neal DE. The management of men with acute urinary retention. National Prostatectomy Audit Steering Group. Br J Urol 1998; 81: 712-20
28. Kawakami J, Nickel JC. Acute urinary retention and surgery for benign prostatic hyperplasia: the patient's perspective. Can J Urol 1999; 6: 819-22
29. Teillac P. Benign prostatic hyperplasia: patients' perception of medical treatment and their expectations: results of a French survey involving patients treated with finasteride. Therapie 2002; 57: 473-83
30. Emberton M, Andriole GL, de la Rosette J et al. Benign prostatic hyperplasia: a progressive disease of aging men. Urology 2003; 61: 267-73
31. Roehrborn CG, Boyle P, Bergner D et al. Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow rate: results of a four-year, randomized trial comparing finasteride versus placebo. PLESS Study Group. Urology 1999; 54: 662-9
32. Barry MJ, Fowler FJ Jr, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK. Measuring disease-specific health status in men with benign prostatic hyperplasia. Measurement Committee of The American Urological Association. Med Care 1995; 33 (Suppl. 4): AS145-55
33. Wagner EH, Barrett P, Barry MJ, Barlow W, Fowler FJ. The effect of a shared decision-making program on rates of surgery for benign prostatic hyperplasia. Pilot results. Med Care 1995; 33: 765-70
34. Watson V, Ryan M, Ellis B, Emberton M, Brown C. Eliciting preferences for benign prostatic hyperplasia medical treatment. Presented at the XIXth Congress of the European Association of Urology, Vienna, Austria, March 2004
35. Mitropoulos D, Anastasiou I, Giannopoulou C et al. Symptomatic benign prostate hyperplasia: impact on partners' quality of life. Eur Urol 2002; 41: 240-4
36. Sells H, Donovan J, Ewings P, MacDonagh RP. The development and validation of a quality-of-life measure to assess partner morbidity in benign prostatic enlargement. BJU Int 2000; 85: 440-5
37. Boyle P, Robertson C, Mazzetta C et al. The relationship between lower urinary tract symptoms and health status: the UREPIK study. BJU Int 2003; 92: 575-80